Edition:
United States

Sensus Healthcare Inc (SRTS.OQ)

SRTS.OQ on NASDAQ Stock Exchange Capital Market

5.97USD
4:00pm EDT
Change (% chg)

$-0.00 (-0.08%)
Prev Close
$5.97
Open
$6.00
Day's High
$6.00
Day's Low
$5.90
Volume
2,464
Avg. Vol
1,368
52-wk High
$6.07
52-wk Low
$3.52

Chart for

About

Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The... (more)

Overall

Beta: --
Market Cap(Mil.): $79.61
Shares Outstanding(Mil.): 13.54
Dividend: --
Yield (%): --

Financials

  SRTS.OQ Industry Sector
P/E (TTM): -- 33.54 33.25
EPS (TTM): -0.28 -- --
ROI: -27.44 9.93 13.13
ROE: -27.53 14.73 14.96

BRIEF-Sensus Healthcare Expands International Business To Meet Rising Patient Demand For Non-Invasive Skin Cancer And Keloid Treatments

* SENSUS HEALTHCARE EXPANDS INTERNATIONAL BUSINESS TO MEET RISING PATIENT DEMAND FOR NON-INVASIVE SKIN CANCER AND KELOID TREATMENTS

Apr 19 2018

BRIEF-Sensus Healthcare Collaborates With Birchbiomed To Treat And Prevent Scarring For Keloids Patients

* SENSUS HEALTHCARE LAUNCHES COLLABORATION WITH BIRCHBIOMED TO TREAT AND PREVENT SCARRING FOR KELOIDS PATIENTS AROUND THE WORLD Source text for Eikon: Further company coverage:

Feb 05 2018

BRIEF-Sensus Healthcare Reports Q4 Loss Per Share $0.03

* SENSUS HEALTHCARE REPORTS RECORD REVENUE FOR 2017 FOURTH QUARTER AND FULL YEAR

Feb 01 2018

BRIEF-Sensus Healthcare files for mixed shelf of up to $20 mln - SEC filing

* Sensus Healthcare Inc files for mixed shelf of up to $20 million - SEC filing Source text: (http://bit.ly/2j7hKwL) Further company coverage:

Nov 06 2017

BRIEF-Sensus Healthcare reports Q3 loss per share of $0.07

* Sensus Healthcare reports third quarter financial results featuring revenue up 44 percent

Nov 02 2017

BRIEF-Sensus Healthcare launches SRT-100 in China for Keloid treatment

* Sensus Healthcare Inc - ‍has launched SRT-100 in China for treatment and prevention of Keloids with Chindex Medical Limited​

Nov 01 2017

BRIEF-Sensus Healthcare says SRT-100 now cleared for sale in Mexico​

* Sensus Healthcare Inc - ‍announces that SRT-100 is now cleared for sale in Mexico​

Oct 31 2017

BRIEF-Stratpharma AG & Sensus Healthcare announce strategic collaboration

* Stratpharma AG & Sensus Healthcare announce strategic collaboration for transformative superficial radiation therapy & post-treatment care Source text for Eikon: Further company coverage:

Oct 23 2017

Earnings vs. Estimates